BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Geng Y, Li G, Zhang L. The Impact of COVID-19 Interventions on Influenza and Mycobacterium Tuberculosis Infection. Front Public Health 2021;9:672568. [PMID: 34095074 DOI: 10.3389/fpubh.2021.672568] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Tovar M, Aleta A, Sanz J, Moreno Y. Modeling the impact of COVID-19 on future tuberculosis burden. Commun Med 2022;2:77. [DOI: 10.1038/s43856-022-00145-0] [Reference Citation Analysis]
2 Zhang J, Nian X, Li X, Huang S, Duan K, Li X, Yang X. The Epidemiology of Influenza and the Associated Vaccines Development in China: A Review. Vaccines 2022;10:1873. [DOI: 10.3390/vaccines10111873] [Reference Citation Analysis]
3 Wang H, Zheng Y, de Jonge MI, Wang R, Verhagen LM, Chen Y, Li L, Xu Z, Wang W. Lockdown measures during the COVID-19 pandemic strongly impacted the circulation of respiratory pathogens in Southern China. Sci Rep 2022;12:16926. [PMID: 36209167 DOI: 10.1038/s41598-022-21430-x] [Reference Citation Analysis]
4 Yang L, He D, Wang L. Editorial: Interference of COVID-19 and Influenza Infections. Front Public Health 2021;9:818199. [PMID: 35004603 DOI: 10.3389/fpubh.2021.818199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chen B, Wang M, Huang X, Xie M, Pan L, Liu H, Liu Z, Zhou P. Changes in Incidence of Notifiable Infectious Diseases in China Under the Prevention and Control Measures of COVID-19. Front Public Health 2021;9:728768. [PMID: 34722440 DOI: 10.3389/fpubh.2021.728768] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 18.0] [Reference Citation Analysis]